Skip to main content
1 March 2021
Last updated:
Sunday 28 February 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us

Research Directory

  • A meeting of minds at AstraZeneca

    Wednesday 18 March 2020
    Interviewee/Contributor
    José Baselga
    Organisation
    AstraZeneca Plc
    Cancer (Oncology)
    Drug discovery
    Strategy
    • Read more about A meeting of minds at AstraZeneca
  • Organs-on-chips enter the laboratories of big pharma

    Sunday 1 July 2018
    Interviewee/Contributor
    Lorna Ewart and Geraldine Hamilton
    Organisation
    AstraZeneca Plc and Emulate Inc
    Drug discovery
    Strategy
    Drug resistance
    • Read more about Organs-on-chips enter the laboratories of big pharma
  • Precision Medicine: The challenge of using big data to help patients

    Sunday 27 March 2016
    Interviewee/Contributor
    Ruth March
    Organisation
    AstraZeneca Plc
    Academic Research
    Biomarker
    Cancer (Oncology)
    Personalised medicine
    • Read more about Precision Medicine: The challenge of using big data to help patients
  • Why AstraZeneca is revisiting olaparib

    Sunday 8 September 2013
    Interviewee/Contributor
    Jane Robertson
    Organisation
    AstraZeneca Plc
    Cancer (Oncology)
    Clinical trials
    • Read more about Why AstraZeneca is revisiting olaparib
  • The art of tapping into academic expertise

    Friday 11 November 2011
    Interviewee/Contributor
    Jane Buus Laursen
    Organisation
    AstraZeneca
    Technology transfer (office)
    Academic Research
    • Read more about The art of tapping into academic expertise
  • Managing Innovation at AstraZeneca

    Monday 30 May 2011
    Interviewee/Contributor
    Shaun Grady
    Organisation
    AstraZeneca
    Strategy
    • Read more about Managing Innovation at AstraZeneca
  • Personalised medicine at AstraZeneca

    Thursday 25 February 2010
    Interviewee/Contributor
    Ruth March
    Organisation
    AstraZeneca
    Personalised medicine
    • Read more about Personalised medicine at AstraZeneca

Organisations

  • Edmond de Rothschild Partners
  • Araris Biotech AG
  • NDA Regulatory Science Ltd
  • The PEW Charitable Trusts
  • ReNeuron Group Plc
  • Allero Therapeutics BV
  • Nantes University Hospital
  • National Institute for Biological Standards and Control
  • Novasecta
  • US Food and Drug Administration

Interviewees and Contributers

  • Chris Martin
  • Gerald Möller
  • Jérôme Van Biervliet
  • Jonathan D Moore
  • Dave Tapolczay
  • Ruxandra Draghia-Akli
  • Paige Bischoff
  • Johannes Jensen
  • MedNous financing article
  • Jan Fagerberg

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Microbiotica expands management team
Wednesday February 10 2021
Philippe Dro joins Scenic Biotech as independent chairman
Wednesday February 10 2021
NOXXON announces senior appointment to its new advisory board
Wednesday February 10 2021
Wendy Levin joins Biofidelity as chief medical officer
Wednesday February 10 2021
VarmX appoints Gerard Short as chief medical officer
Wednesday February 10 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.